Skip to content
10-K

Annual Report

OPTIMER PHARMACEUTICALS INC

0001104659-13-021766

← back to feed
Filed
Mar 18, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 11, 2013 47.9M sh
Shares Diluted FY 2012 · Dec 31, 2012 47.33M sh
Shares Diluted restated FY 2012 · Dec 31, 2011 46.5M sh
Shares Diluted FY 2012 · Dec 31, 2010 37.83M sh
Capex FY 2012 · Dec 31, 2012 $2.9M
Capex FY 2012 · Dec 31, 2011 $2.44M
Capex FY 2012 · Dec 31, 2010 $305.99K
Short Term Investments FY 2012 · Dec 31, 2012 $4.56M
Short Term Investments FY 2012 · Dec 31, 2011 $78.79M
Cash And Equivalents FY 2012 · Dec 31, 2012 $119.44M
Cash And Equivalents FY 2012 · Dec 31, 2011 $31.79M
Cash And Equivalents FY 2012 · Dec 31, 2010 $19.86M
Cash And Equivalents FY 2012 · Dec 31, 2009 $17.05M
Stockholders Equity FY 2012 · Dec 31, 2012 $130.81M
Stockholders Equity FY 2012 · Dec 31, 2011 $143.9M
Current Liabilities FY 2012 · Dec 31, 2012 $26.79M
Current Liabilities FY 2012 · Dec 31, 2011 $31.31M
Current Assets FY 2012 · Dec 31, 2012 $152.02M
Current Assets FY 2012 · Dec 31, 2011 $177.16M
Total Assets FY 2012 · Dec 31, 2012 $159.43M
Total Assets FY 2012 · Dec 31, 2011 $182.02M
Eps Diluted FY 2012 · Dec 31, 2012 $0.02
Eps Diluted FY 2012 · Dec 31, 2012 −$0.78
Eps Diluted FY 2012 · Sep 30, 2012 −$0.56
Eps Diluted FY 2012 · Jun 30, 2012 −$0.01
Eps Diluted FY 2012 · Mar 31, 2012 −$0.23
Eps Diluted FY 2012 · Dec 31, 2011 $0.28
Eps Diluted FY 2012 · Dec 31, 2011 $0.17
Eps Diluted FY 2012 · Sep 30, 2011 −$0.57
Eps Diluted FY 2012 · Jun 30, 2011 −$0.52
Eps Diluted FY 2012 · Mar 31, 2011 $1.04
Eps Diluted FY 2012 · Dec 31, 2010 −$1.25
Eps Basic FY 2012 · Dec 31, 2012 $0.02
Eps Basic FY 2012 · Dec 31, 2012 −$0.78
Eps Basic FY 2012 · Sep 30, 2012 −$0.56
Eps Basic FY 2012 · Jun 30, 2012 −$0.01
Eps Basic FY 2012 · Mar 31, 2012 −$0.23
Eps Basic FY 2012 · Dec 31, 2011 $0.29
Eps Basic FY 2012 · Dec 31, 2011 $0.17
Eps Basic FY 2012 · Sep 30, 2011 −$0.57
Eps Basic FY 2012 · Jun 30, 2011 −$0.52
Eps Basic FY 2012 · Mar 31, 2011 $1.06
Eps Basic FY 2012 · Dec 31, 2010 −$1.25
Sga Expense FY 2012 · Dec 31, 2012 $112.03M
Sga Expense restated FY 2012 · Dec 31, 2011 $80.57M
Sga Expense FY 2012 · Dec 31, 2010 $17.55M
Rd Expense FY 2012 · Dec 31, 2012 $45.2M
Rd Expense FY 2012 · Dec 31, 2011 $43.09M
Rd Expense FY 2012 · Dec 31, 2010 $32.8M
Operating Income FY 2012 · Dec 31, 2012 −$30.32M
Operating Income FY 2012 · Dec 31, 2012 −$90.84M
Operating Income FY 2012 · Sep 30, 2012 −$26.27M
Operating Income FY 2012 · Jun 30, 2012 $328K
Operating Income FY 2012 · Mar 31, 2012 −$34.57M
Operating Income FY 2012 · Dec 31, 2011 $12.75M
Operating Income FY 2012 · Dec 31, 2011 $5.64M
Operating Income FY 2012 · Sep 30, 2011 −$26.91M
Operating Income FY 2012 · Jun 30, 2011 −$25.02M
Operating Income FY 2012 · Mar 31, 2011 $44.82M
Operating Income FY 2012 · Dec 31, 2010 −$48.87M
Cost Of Revenue FY 2012 · Dec 31, 2012 $1.36M
Cost Of Revenue FY 2012 · Dec 31, 2012 $5.49M
Cost Of Revenue FY 2012 · Sep 30, 2012 $1.42M
Cost Of Revenue FY 2012 · Jun 30, 2012 $1.48M
Cost Of Revenue FY 2012 · Mar 31, 2012 $1.22M
Cost Of Revenue FY 2012 · Dec 31, 2011 $1.53M
Revenue FY 2012 · Dec 31, 2012 $19.52M
Revenue FY 2012 · Dec 31, 2012 $101.53M
Revenue FY 2012 · Sep 30, 2012 $17.88M
Revenue FY 2012 · Jun 30, 2012 $49.76M
Revenue FY 2012 · Mar 31, 2012 $14.38M
Revenue FY 2012 · Dec 31, 2011 $64.62M
Revenue FY 2012 · Dec 31, 2011 $144.98M
Revenue FY 2012 · Sep 30, 2011 $11.05M
Revenue FY 2012 · Jun 30, 2011 $33K
Revenue FY 2012 · Mar 31, 2011 $69.28M
Revenue FY 2012 · Dec 31, 2010 $1.48M
Stock Issued FY 2012 · Feb 28, 2011 6.9M sh
Stock Issued FY 2012 · Mar 31, 2010 4.89M sh